Pfizer’s Omicron Vaccine; SEC Chair’s 2022 Goals; Novak’s Courtside Drama
Pfizer CEO Albert Bourla says the company will have an omicron vaccine ready by March, just in case. He discusses global vaccine distribution, the covid treatment pill, and what he’s hoping for in 2022 with CNBC’s Meg Tirrell, Becky Quick, and Andrew Ross Sorkin. SEC Chairman Gary Gensler discusses regulatory goals on his 2022 docket, including bolstering transparency for investors. Plus, China is attempting to mitigate a surge of Omicron before the Winter Olympics, and tennis champion Novak Djokovic’s Aussie drama continues, courtside. In this episode: Gary Gensler, @GaryGensler Albert Bourla, @AlbertBourla Meg Tirrell, @megtirrell Becky Quick, @BeckyQuick Andrew Ross Sorkin, @andrewrsorkin Cameron Costa, @CameronCostaNY
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Pfizer CEO Albert Bourla says the company will have an omicron vaccine ready by March, just in case. He discusses global vaccine distribution, the covid treatment pill, and what he’s hoping for in 2022 with CNBC’s Meg Tirrell, Becky Quick, and Andrew Ross Sorkin. SEC Chairman Gary Gensler discusses regulatory goals on his 2022 docket, including bolstering transparency for investors. Plus, China is attempting to mitigate a surge of Omicron before the Winter Olympics, and tennis champion Novak Djokovic’s Aussie drama continues, courtside.
In this episode:
Gary Gensler, @GaryGensler
Albert Bourla, @AlbertBourla
Meg Tirrell, @megtirrell
Becky Quick, @BeckyQuick
Andrew Ross Sorkin, @andrewrsorkin
Cameron Costa, @CameronCostaNY
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.